Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in Bulimia Nervosa
NCT01131572Phase 3Terminated
- Sponsor
- Lindner Center of HOPE
- Start
- Feb 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in bulimia nervosa (BN), sponsored by Lindner Center of HOPE. Started Feb 2010; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
bulimia nervosa (BN)
Beyond the preview
Go deeper on NCT01131572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131572.